ASP Isotopes receives regulatory approval for Renergen acquisition

ASP Isotopes (ASPI) announced that all required regulatory approvals and clearances have been obtained for ASP Isotopes’ proposed offer to acquire all of the issued ordinary shares of JSE-listed Renergen (RGNNF), pursuant to a scheme of arrangement under South African law pursuant to which Renergen shareholders will receive 0.09196 new ASP Isotopes shares for each Renergen share held on the record date. Accordingly, all remaining conditions precedent have been fulfilled or, where applicable, waived and the Scheme has become unconditional. Implementation of the Scheme will begin once the South African Takeover Regulation Panel issues the requisite compliance certificate, which is anticipated to be received on or about December 18. Upon receipt of the compliance certificate, ASP Isotopes and Renergen will publish the finalization announcement, containing the remaining salient dates and times for implementation of the Scheme.